Jane Street’s Psyence Biomedical PBM Stock Holding History

Jane Street’s Portfolio PBM Stock Details PBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12	Closed	-$4.6K	–	10785
2024 Q3	$4.6K	Buy	+12	New	+$16.2K	﹤0.01%	9408

Other funds holding PBM

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

HCI

Harraden Circle Investments New York $499M AUM 19.71% 1-Year Est. Return

Essential Planning Portsmouth, New Hampshire $354M AUM 14.58% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Jane Street's PBM Position: Q4 2024 in Review

Jane Street sold out of Psyence Biomedical (PBM) in Q4 2024, closing a stake of 12 shares — an estimated $4.6K sold.

Jane Street first reported a position in PBM in Q3 2024 and held it in 1 quarter. The position peaked at $4.6K in Q3 2024. 11 funds tracked by Wall St. Rank hold PBM as of Q4 2024.

Jane Street reported no remaining Psyence Biomedical position as of Q4 2024 after selling out during the quarter.
Jane Street sold 12 Psyence Biomedical shares in Q4 2024, an estimated $4.6K.
Jane Street first reported a position in Psyence Biomedical in Q3 2024 and held it in 1 quarter.
Jane Street's Psyence Biomedical position peaked at $4.6K in Q3 2024.
11 funds tracked by Wall St. Rank held Psyence Biomedical as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.